Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Zeitschrift Fur Rheumatologie|January 24, 2025
[T-cell large granular lymphocytic leukemia and Felty's syndrome in rheumatoid arthritis]Michael Gernert, Eva Christina Schwaneck, Marc Schmalzing
Therapeutic Advances in Musculoskeletal Disease|December 2, 2025
Clinical and immunological long-term outcomes after autologous hematopoietic stem cell transplantation in systemic sclerosis: a retrospective single-center experienceMichael Gernert, Jörg Henes, Patrick-Pascal Strunz, et al.
Arthritis Research & Therapy|May 1, 2019
Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine patternMichael Gernert, Hans-Peter Tony, Eva Christina Schwaneck, et al.
The Open Rheumatology Journal|September 28, 2018
Tocilizumab in Large Vessel Vasculitis - Different Routes of AdministrationMarc Schmalzing, Ottar Gadeholt, Michael Gernert, et al.
Frontiers in Immunology|February 3, 2022
Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of RituximabMichael Gernert, Hans-Peter Tony, Matthias Fröhlich, et al.
Arthritis Research & Therapy|August 11, 2020
Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantationMichael Gernert, Hans-Peter Tony, Eva Christina Schwaneck, et al.
Frontiers in Immunology|May 17, 2021
Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine ConditionsJana Heim, Giovanni Almanzar, Marc Schmalzing, et al.
Frontiers in Immunology|March 26, 2026
Case Report: Switching secukinumab to bimekizumab in diffuse cutaneous systemic sclerosis after autologous hematopoietic stem cell transplantation: a case follow-upLea-Kristin Nagler, Patrick-Pascal Strunz, Hannah Labinsky, et al.
Arthritis Research & Therapy|August 19, 2022
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapyMichael Gernert, Marc Schmalzing, Hans-Peter Tony, et al.
Frontiers in Immunology|December 4, 2023
Case Report: Effectiveness of secukinumab in systemic sclerosis with early skin progress after autologous hematopoietic stem cell transplantation and end-stage kidney diseasePatrick-Pascal Strunz, Hannah Labinsky, Lea-Kristin Nagler, et al.
Pageof 5